NHLBI Catalyze Program

Offers funding, technical services, training, and mentorship to help transform scientific discoveries into promising healthcare products, such as diagnostics, therapeutics, and devices. Supports product definition studies, preclinical research, and the development of cutting-edge platform technologies.

Program Officers

Albert Lee, Ph.D.
Enabling Technologies and Transformative Platforms - Heart
301.435.0567
Sara Lin, Ph.D.
Enabling Technologies and Transformative Platforms - Lung
301.435.0222
Margaret Ochocinska, Ph.D.
Enabling Technologies and Transformative Platforms - Blood
301.827.8285
Marishka Brown, Ph.D.
Enabling Technologies and Transformative Platforms - Sleep
301.827.7822
Narasimhan Danthi, Ph.D.
Product Definition - Small molecules and Biologics
301.451.5170
Marc Charette, Ph.D.
Product Definition - Small molecules and Biologics
301.435.0560
Albert Lee, Ph.D.
Product Definition - Device, Diagnostics and Tools
301.435.0567
Narasimhan Danthi, Ph.D.
Product Definition – Device, Diagnostics and Tools (Imaging Technologies)
301.451.5170
Denis Buxton, Ph.D.
Product Definition - Device, Diagnostics and Tools
301.435.0515